Genmab — Januar 2025

[E_L]

CLL is Still in Retreat on My Epcoritamab Trial https://cllsociety.org/2025/01/cll-is-still-in-retreat-on-my-epcoritamab-trial/

[lahn1]

Dejligt med positive patienthistorier

[E_L]

another small new trial - Epcoritamab and Tazemetostat for the Treatment of Relapsed or Refractory Grade I-IIIa Follicular Lymphoma https://clinicaltrials.gov/study/NCT06575686

[E_L]

January 8, 2025
H.C. Wainwright analyst Raghuram Selvaraju reiterated a Buy rating and $50.00 price target on Genmab https://www.streetinsider.com/Analyst+Comments/H.C.+Wainwright+Reiterates+Buy+Rating+on+Genmab+AS+(GMAB)/24184756.html

[E_L]

TD Cowen maintains
a hold

[Vitus]

Kurs 1600 er en hurdle !

[JKY_VH]

ja nedefra og op:-)

[Helge_LarsenPI-redaktør]

Godmorgen

[Stroka]

God morgen

[LP90]

Godmorgen

[Plimsoller]

God morgen

[E_L]

slide shows the Evaluate Pharma forecast for Darzalex up to $17.5bn in 2028 https://x.com/BertrandBio/status/1877059350172143702/photo/1

[E_L]

maybe Jan will end up being right about what he said on Dara in September 'I think in the end of three years from now, it's going to be one of the top three biggest cancer drugs '

[gentogen]

Ja. I det lys må man jo også medgive, at det er rendyrket KYSO, hvis Erzo er bedre...faktisk en vanvittig præstation (i givet fald)...

[E_L]

Epkinly US list price change +2.0% per 1/1/25

[ProinvestorNEWS]

Kort ugevideo...
Trump-trussel, Vestas, Novo Nordisk, Bavarian og Anavex https://proinvestor.com/boards/124029

[ProinvestorNEWS]

Knock-Your-Socks-Off-News – January 2025 https://www.linkedin.com/pulse/knock-your-socks-off-news-january-2025-genmab-mkuze/

[M_T_A]

En Medical Affairs VP fra JnJ's Oncology afdeling har sagt op eller er blevet fyret. Fundet på CafePharma.

[M_T_A]

Solid Tumor Oncology Leadership

VP MA first casualty of the year....

Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales (www.cafepharma.com)

[M_T_A]

Aner ikke om der kan være noget i det, men timingen er lidt sjov med Erzotabart
i tankerne.